Crossref journal-article
Public Library of Science (PLoS)
PLoS ONE (340)
Bibliography

Manocheewa, S., Swain, J. V., Lanxon-Cookson, E., Rolland, M., & Mullins, J. I. (2013). Fitness Costs of Mutations at the HIV-1 Capsid Hexamerization Interface. PLoS ONE, 8(6), e66065.

Authors 5
  1. Siriphan Manocheewa (first)
  2. J. Victor Swain (additional)
  3. Erinn Lanxon-Cookson (additional)
  4. Morgane Rolland (additional)
  5. James I. Mullins (additional)
References 33 Referenced 28
  1. 10.1016/j.sbi.2008.02.001 / Curr Opin Struct Biol / The structural biology of HIV assembly by BK Ganser-Pornillos (2008)
  2. 10.1126/science.283.5398.80 / Science / Assembly and analysis of conical models for the HIV-1 core by BK Ganser (1999)
  3. 10.1093/emboj/cdg143 / EMBO J / Structural organization of authentic, mature HIV-1 virions and cores by JA Briggs (2003)
  4. 10.1093/emboj/18.5.1124 / EMBO J / Head-to-tail dimers and interdomain flexibility revealed by the crystal structure of HIV-1 capsid protein (p24) complexed with a monoclonal antibody Fab by C Berthet-Colominas (1999)
  5. 10.1016/j.cell.2009.04.063 / Cell / X-ray structures of the hexameric building block of the HIV capsid by O Pornillos (2009)
  6. 10.1128/JVI.76.11.5667-5677.2002 / J Virol / Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication by BM Forshey (2002)
  7. 10.1128/JVI.77.9.5439-5450.2003 / J Virol / Functional surfaces of the human immunodeficiency virus type 1 capsid protein by UK von Schwedler (2003)
  8. 10.1074/jbc.M804230200 / J Biol Chem / Residues in the HIV-1 capsid assembly inhibitor binding site are essential for maintaining the assembly-competent quaternary structure of the capsid protein by V Bartonova (2008)
  9. 10.1128/JVI.75.19.9357-9366.2001 / J Virol / Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells by S Tang (2001)
  10. Bocanegra R, Rodriguez-Huete A, Fuertes MA, Del Alamo M, Mateu MG (2012) Molecular recognition in the human immunodeficiency virus capsid and antiviral design. Virus Res. (10.1016/j.virusres.2012.06.016)
  11. 10.1128/JVI.68.7.4650-4655.1994 / J Virol / Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome by RA Koup (1994)
  12. 10.1038/nm1520 / Nat Med / CD8+ T-cell responses to different HIV proteins have discordant associations with viral load by P Kiepiela (2007)
  13. 10.1128/JVI.00575-06 / J Virol / Selection on the human immunodeficiency virus type 1 proteome following primary infection by Y Liu (2006)
  14. 10.1128/JVI.79.21.13239-13249.2005 / J Virol / Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution by TM Allen (2005)
  15. 10.1371/journal.ppat.0030157 / PLoS Pathogens / HIV-1 Group M Conserved Elements Vaccine by M Rolland (2007)
  16. 10.1371/journal.pone.0029717 / PLoS ONE / CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV control by B Mothe (2012)
  17. 10.1093/nar/gkn860 / Nucleic Acids Res / PDBsum new things by RA Laskowski (2009)
  18. Maddison WP, Maddison DR (2011) Mesquite: a modular system for evolutionary analysis. 2.75 ed.
  19. Nickle DC, Jensen MA, Gottlieb GS, Shriner D, Learn GH, et al.. (2003) Consensus and ancestral state HIV vaccines. Science 299: 1515–1518; author reply 1515–1518. (10.1126/science.299.5612.1515c)
  20. 10.2144/000113370 / Biotechniques / DIVEIN: A Web Server to Analyze Phylogenies, Sequence Divergence, Diversity, and Informative Sites by W Deng (2010)
  21. 10.1097/QAI.0b013e318030f5c5 / J Acquir Immune Defic Syndr / Granulocyte-monocyte colony-stimulating factor upregulates HIV-1 replication in monocyte-derived macrophages cultured at low density by J McClure (2007)
  22. {'key': 'ref22', 'first-page': '493', 'article-title': 'A simple method of estimating fifty percent endpoints', 'volume': '27', 'author': 'LJ Reed', 'year': '1938', 'journal-title': 'Am J Hyg'} / Am J Hyg / A simple method of estimating fifty percent endpoints by LJ Reed (1938)
  23. 10.1371/journal.ppat.1000365 / PLoS Pathog / Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response by RM Troyer (2009)
  24. Liu Y, Mullins JI, etal (2012) A sensitive real-time PCR based assay to estimate the impact of amino acid substitutions on the competitive replication fitness of human immunodeficiency virus type 1 in cell culture. Journal of Virological Methods: In Press. (10.1016/j.jviromet.2012.10.016)
  25. 10.1186/1471-2105-11-261 / BMC Bioinformatics / vFitness: a web-based computing tool for improving estimation of in vitro HIV-1 fitness experiments by J Ma (2010)
  26. 10.1128/JVI.80.5.2380-2389.2006 / J Virol / Modeling and estimation of replication fitness of human immunodeficiency virus type 1 in vitro experiments by using a growth competition assay by H Wu (2006)
  27. 10.1128/JVI.02683-06 / J Virol / Reconstruction and function of ancestral center-of-tree human immunodeficiency virus type 1 proteins by M Rolland (2007)
  28. 10.1371/journal.pcbi.1000225 / PLoS Comput Biol / Phylogenetic dependency networks: inferring patterns of CTL escape and codon covariation in HIV-1 Gag by JM Carlson (2008)
  29. 10.1038/nature09640 / Nature / Atomic-level modelling of the HIV capsid by O Pornillos (2011)
  30. 10.1016/j.jmb.2012.01.014 / J Mol Biol / A structural model for the generation of continuous curvature on the surface of a retroviral capsid by GD Bailey (2012)
  31. Rolland M, Manocheewa S, Swain JV, Lanxon-Cookson EC, Kim M, et al.. (2013) HIV-1 conserved elements vaccines: Relationship between sequence conservation and replicative capacity. J Virol. (10.1128/JVI.03033-12)
  32. 10.1186/1479-5876-9-208 / J Transl Med / Definition of the viral targets of protective HIV-1-specific T cell responses by B Mothe (2011)
  33. 10.1016/j.vaccine.2010.12.131 / Vaccine / Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes by L Niu (2011)
Dates
Type When
Created 12 years, 2 months ago (June 13, 2013, 5:11 p.m.)
Deposited 5 years, 1 month ago (July 28, 2020, 6:52 a.m.)
Indexed 2 months, 3 weeks ago (June 8, 2025, 2:22 p.m.)
Issued 12 years, 2 months ago (June 13, 2013)
Published 12 years, 2 months ago (June 13, 2013)
Published Online 12 years, 2 months ago (June 13, 2013)
Funders 0

None

@article{Manocheewa_2013, title={Fitness Costs of Mutations at the HIV-1 Capsid Hexamerization Interface}, volume={8}, ISSN={1932-6203}, url={http://dx.doi.org/10.1371/journal.pone.0066065}, DOI={10.1371/journal.pone.0066065}, number={6}, journal={PLoS ONE}, publisher={Public Library of Science (PLoS)}, author={Manocheewa, Siriphan and Swain, J. Victor and Lanxon-Cookson, Erinn and Rolland, Morgane and Mullins, James I.}, editor={Barbour, Jason D.}, year={2013}, month=jun, pages={e66065} }